Abstract
The regulatory authority in the UK, the Committee on Safety of Medicines, issued advice to health professionals on the day the results of the Million Women Study (MWS) were published. This course of action was undertaken before review of the study by the international medical and scientific community. We have reviewed the methodology of the MWS. It is our belief that the flaws in the design render the results largely uninterpretable because built in biases have affected risk estimates.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beral, V. and Million Women SC. (2003). Lancet 362, 419–427.
The Million Women Study Collaborative Group. (1999). Breast Cancer Research 1, 73–80.
Banks, E., Beral, V., Cameron, R., et al. (2001). J. Epidemiol. Biostat. 6, 357–363.
Vandenbroucke, J. P., van Leeuwen, F. E., and Helmerhorst, F. M. (2003). Nederlands Tijdschrift voor Geneeskunde 147, 1829–1834.
Doren, M. (2003). Maturitas 46, 93–94.
Lagro-Janssen, T., Rosser, W. W., and van Weel, C. (2003). Lancet 362, 414–415.
Garton, M. (2003). Lancet 362, 1328, (author’s reply) 1330–1331.
Bliss, J. M. and Gray, R. (2003). Lancet 362, 1328–1329.
Bundred, N. J. and Morris, J. (2003). Lancet 362, 1329, (author’s reply) 1330–1331.
Van Leeuwen, F. E. and Rookus, M. A. (2003). Lancet 362, 1330–1331.
Braendle, W. (2003). Maturitas 46, 101–102.
Patnick, J. (2003). Breast Screening Programme, England, 2002–2003.
Bromley, S. E., de Vries, C. S., and Farmer, R. D. (2004). BJOG 111, 369–376.
Speroff, L. (2003). Maturitas 46, 1–6.
Hill, A. B. (1965). Proc. R. Soc. Med. 58, 295–300.
Collaborative Group on Hormonal Factors in Breast Cancer. (1997). Lancet 350, 1047–1059.
Rossouw, J. E., Anderson, G. L., Prentice, R. L., et al., Writing Group for the Women’s Health Initiative Investigators. (2002). JAMA 288, 321–333.
Chlebowski, R. T., Hendrix, S. L., Langer, R. D., et al., Investigators WHI. (2003). JAMA 289, 3243–3253.
Beral, V., Banks, E., and Reeves, G. (2002). Lancet 360, 942–944.
Beral, V., Banks, E., Reeves, G., and Appleby, P. (1999). J. Epidemiol. Biostat. 4, 191–210.
Bergkvist, L., Adami, H. O., Persson, I., Hoover, R., and Schairer, C. (1989). N. Engl. J. Med. 321, 293–297.
Magnusson, C., Baron, J. A., Correia, N., Bergstrom, R., Adami, H. O., and Persson, I. (1999). Int. J. Cancer 81, 339–344.
Schairer, C., Lubin, J., Troisi, R., Sturgeon, S., Brinton, L., and Hoover, R. (2000). JAMA 283, 485–491.
Ross, R. K., Paganini-Hill, A., Wan, P. C., and Pike, M. C. (2000). J. Natl. Cancer Inst. 92, 328–332.
Li, C. I., Malone, K. E., Porter, P. L., et al. (2003). JAMA 289, 3254–3263.
Bush, T. L., Whiteman, M., and Flaws, J. A. (2001). Obstet. Gynecol. 98, 498–508.
Anderson, G. L., Limacher, M., Assaf, A. R., et al., Women’s Health Initiative Steering Committee. (2004). JAMA 291, 1701–1712.
Kopernik, G. and Shoham, Z. (2004). Fertil. Steril. 81, 1458–1477.
Heuser, L., Spratt, J. S., and Polk, H. C. Jr. (1979). Cancer 43, 1888–1894.
Gullino, P. M. (1977). Cancer 39, Suppl.-703.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Whitehead, M., Farmer, R. The million women study. Endocr 24, 187–193 (2004). https://doi.org/10.1385/ENDO:24:3:187
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:24:3:187